1. EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL). (February 2017) Authors: Ascierto, P.; Bastholt, L.; Mohr, P.; Hoeller, C.; Robert, C.; Larkin, J.; Dummer, R.; Ekbom, A.; Chiarion-Sileni, V.; Dutriaux, C.; Mortier, L.; Neyns, B.; Nyakas, M.; Garbe, C.; Baurain, J.F.; Kruse, V.; Svane, I.M.; Alfaya, L.; Ciria, C.; Blank, C. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statement. Issue 1 (January 2020) Authors: Peach, H.; Board, R.; Cook, M.; Corrie, P.; Ellis, S.; Geh, J.; King, P.; Laitung, G.; Larkin, J.; Marsden, J.; Middleton, M.; Moncrieff, M.; Nathan, P.; Powell, B.; Pritchard-Jones, R.; Rodwell, S.; Steven, N.; Lorigan, P. Journal: Journal of plastic, reconstructive & aesthetic surgery Issue: Volume 73:Issue 1(2020) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development of a highly sensitive chemiluminescence immunoassay for detection of aggrecanase-generated args aggrecan fragments in serum. Issue 1 (April 2020) Authors: He, Y.; Siebuhr, A.; Karsdal, M.; Larkin, J.; Bay-Jensen, A.-C. Journal: Osteoarthritis and cartilage Issue: Volume 28:Issue 1(2020)supplement Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 25LBA Impact of baseline genetic heterogeneities on progression-free survival (PFS) in patients (pts) with advanced BRAFV600-mutated melanoma treated with cobimetinib (COBI) + vemurafenib (VEM) in the phase 3 coBRIM study. (September 2015) Authors: McArthur, G.; Larkin, J.; Dréno, B.; Ascierto, P.; Liszkay, G.; Maio, M.; Mandal´, M.; Demidov, L.; Stroyakovskiy, D.; Thomas, L.; De la Cruz-Merino, L.; Atkinson, V.; Dutriaux, C.; Garbe, C.; Wongchenko, M.; Hsu, J.; Koralek, D.; Rooney, I.; Yan, Y.; Ribas, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3303 Efficacy and safety in key patient subgroups of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naïve patients with advanced melanoma (MEL) (CheckMate 067). (September 2015) Authors: Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J.J.; Cowey, C.L.; Lao, C.D.; Wagstaff, J.; Hogg, D.; Hill, A.; Carlino, M.S.; Wolter, P.; Lebbé, C.; Schachter, J.; Thomas, L.; Hassel, J.C.; Lorigan, P.; Walker, D.; Jiang, J.; Hodi, F.S.; Wolchok, J.D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Searching for solar KDAR with DUNE. Issue 10 (22nd October 2021) Authors: Abed Abud, A.; Abi, B.; Acciarri, R.; Acero, M.A.; Adames, M.R.; Adamov, G.; Adams, D.; Adinolfi, M.; Aduszkiewicz, A.; Aguilar, J.; Ahmad, Z.; Ahmed, J.; Ali-Mohammadzadeh, B.; Alion, T.; Allison, K.; Alonso Monsalve, S.; Alrashed, M.; Alt, C.; Alton, A.; Amedo, P. Other Names: collab. Journal: Journal of cosmology and astroparticle physics Issue: Volume 2021:Issue 10(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Therapeutic Potential for Targeting the Suppressor of Cytokine Signalling‐1 Pathway for the Treatment of SLE. (26th October 2016) Authors: Sukka‐Ganesh, B.; Larkin, J. Journal: Scandinavian journal of immunology Issue: Volume 84:Number 5(2016:Nov.) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma. (6th March 2016) Authors: Spain, L.; Higgins, R.; Gopalakrishnan, K.; Turajlic, S.; Gore, M.; Larkin, J. Journal: Annals of oncology Issue: Volume 27:Number 6(2016:Jun.) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Design, construction and operation of the ProtoDUNE-SP Liquid Argon TPC. (4th January 2022) Authors: Abed Abud, A.; Abi, B.; Acciarri, R.; Acero, M.A.; Adames, M.R.; Adamov, G.; Adams, D.; Adinolfi, M.; Aduszkiewicz, A.; Aguilar, J.; Ahmad, Z.; Ahmed, J.; Ali-Mohammadzadeh, B.; Alion, T.; Allison, K.; Alonso Monsalve, S.; Alrashed, M.; Alt, C.; Alton, A.; Amedo, P. Other Names: collab. Journal: Journal of instrumentation Issue: Volume 17:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 432 Correlative analyses of serum biomarkers and clinical outcomes in the phase 2 study of lenvatinib, everolimus, and the combination, in patients with metastatic renal cell carcinoma following 1 VEGF-targeted therapy. (September 2015) Authors: Glen, H.; Hsieh, J.; Michaelson, M.D.; Kim, H.J.; Sachdev, P.; Kadowaki, T.; Funahashi, Y.; Larkin, J.; Motzer, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗